235 related articles for article (PubMed ID: 22847218)
1. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.
Furukawa K; Preston D; Funamoto S; Yonehara S; Ito M; Tokuoka S; Sugiyama H; Soda M; Ozasa K; Mabuchi K
Int J Cancer; 2013 Mar; 132(5):1222-6. PubMed ID: 22847218
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
3. Solid cancer incidence in atomic bomb survivors: 1958-1998.
Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
[TBL] [Abstract][Full Text] [Related]
4. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.
Hayashi Y; Lagarde F; Tsuda N; Funamoto S; Preston DL; Koyama K; Mabuchi K; Ron E; Kodama K; Tokuoka S
Cancer; 2010 Apr; 116(7):1646-55. PubMed ID: 20120034
[TBL] [Abstract][Full Text] [Related]
5. The proportion of thyroid cancers in the Japanese atomic bomb survivors associated with natural background radiation.
Little MP
J Radiol Prot; 2002 Sep; 22(3):279-91. PubMed ID: 12375789
[TBL] [Abstract][Full Text] [Related]
6. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
[TBL] [Abstract][Full Text] [Related]
7. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
Richardson DB
Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
[TBL] [Abstract][Full Text] [Related]
8. Risk of Prostate Cancer Incidence among Atomic Bomb Survivors: 1958-2009.
Mabuchi K; Preston DL; Brenner AV; Sugiyama H; Utada M; Sakata R; Sadakane A; Grant EJ; French B; Cahoon EK; Ozasa K
Radiat Res; 2021 Jan; 195(1):66-76. PubMed ID: 33181833
[TBL] [Abstract][Full Text] [Related]
9. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.
Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
Radiat Res; 2017 May; 187(5):513-537. PubMed ID: 28319463
[TBL] [Abstract][Full Text] [Related]
10. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
Ron E; Lubin JH; Shore RE; Mabuchi K; Modan B; Pottern LM; Schneider AB; Tucker MA; Boice JD
Radiat Res; 1995 Mar; 141(3):259-77. PubMed ID: 7871153
[TBL] [Abstract][Full Text] [Related]
12. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
[TBL] [Abstract][Full Text] [Related]
13. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors.
Little MP; Boice JD
Radiat Res; 1999 Feb; 151(2):218-24. PubMed ID: 9952307
[TBL] [Abstract][Full Text] [Related]
14. Cancer risks and biomarker studies in the atomic bomb survivors.
Preston D
Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
[TBL] [Abstract][Full Text] [Related]
15. Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.
Cahoon EK; Preston DL; Pierce DA; Grant E; Brenner AV; Mabuchi K; Utada M; Ozasa K
Radiat Res; 2017 May; 187(5):538-548. PubMed ID: 28323575
[TBL] [Abstract][Full Text] [Related]
16. Thyroid cancer after diagnostic administration of iodine-131.
Hall P; Mattsson A; Boice JD
Radiat Res; 1996 Jan; 145(1):86-92. PubMed ID: 8532842
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.
Ozasa K; Shimizu Y; Suyama A; Kasagi F; Soda M; Grant EJ; Sakata R; Sugiyama H; Kodama K
Radiat Res; 2012 Mar; 177(3):229-43. PubMed ID: 22171960
[TBL] [Abstract][Full Text] [Related]
18. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
19. Radiation and cancer risk in atomic-bomb survivors.
Kodama K; Ozasa K; Okubo T
J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
[TBL] [Abstract][Full Text] [Related]
20. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer.
Land CE
JAMA; 1995 Aug; 274(5):402-7. PubMed ID: 7616636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
